Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 303

    1.

    Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes.

    Højlund K, Staehr P, Hansen BF, Green KA, Hardie DG, Richter EA, Beck-Nielsen H, Wojtaszewski JF.

    Diabetes. 2003 Jun;52(6):1393-402.PMID: 12765949 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.

    Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH.

    Diabetologia. 2002 Jun;45(6):813-22. Epub 2002 May 8.PMID: 12107725 [PubMed - indexed for MEDLINE]Related articles

    3.

    The effect of acute (60 minute) insulin stimulation upon human skeletal muscle glycogen synthase and protein phosphatase-1 in non-insulin-dependent diabetic patients and control subjects.

    Barriocanal LA, Borthwick AC, Stewart M, Wells A, Hurel SJ, Yeaman SJ, Taylor R.

    Diabet Med. 1995 Dec;12(12):1110-5.PMID: 8750222 [PubMed - indexed for MEDLINE]Related articles

    4.

    Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

    Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR.

    Diabetes. 2000 Feb;49(2):263-71.PMID: 10868943 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

    Glintborg D, Højlund K, Andersen NR, Hansen BF, Beck-Nielsen H, Wojtaszewski JF.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3618-26. Epub 2008 Jun 10.PMID: 18544618 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Impact of genetic versus environmental factors on the control of muscle glycogen synthase activation in twins.

    Poulsen P, Wojtaszewski JF, Petersen I, Christensen K, Richter EA, Beck-Nielsen H, Vaag A.

    Diabetes. 2005 May;54(5):1289-96.PMID: 15855312 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.

    Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB.

    J Clin Invest. 1999 Sep;104(6):733-41.PMID: 10491408 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia.

    Nikoulina SE, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Henry RR.

    Diabetes. 1997 Jun;46(6):1017-24.PMID: 9166674 [PubMed - indexed for MEDLINE]Related articles

    10.

    Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients.

    Krook A, Björnholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr, Wallberg-Henriksson H, Zierath JR.

    Diabetes. 2000 Feb;49(2):284-92.PMID: 10868945 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.

    Liu Z, Wu Y, Nicklas EW, Jahn LA, Price WJ, Barrett EJ.

    Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E523-8. Epub 2003 Dec 2.PMID: 14656717 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation.

    Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, Henry RR.

    J Clin Endocrinol Metab. 2001 Sep;86(9):4307-14.PMID: 11549666 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.

    Christ-Roberts CY, Pratipanawatr T, Pratipanawatr W, Berria R, Belfort R, Mandarino LJ.

    J Appl Physiol. 2003 Dec;95(6):2519-29. Epub 2003 Aug 8.PMID: 12909611 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.

    Højlund K, Frystyk J, Levin K, Flyvbjerg A, Wojtaszewski JF, Beck-Nielsen H.

    Diabetologia. 2006 Jun;49(6):1283-91. Epub 2006 Apr 12.PMID: 16609880 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].

    Storgaard H, Song XM, Jensen CB, Madsbad S, Björnholm M, Vaag A, Zierath JR.

    Diabetes. 2001 Dec;50(12):2770-8. Erratum in: Diabetes 2002 Feb;51(2):552. PMID: 11723060 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Insulin unexpectedly increases the glucose 6-phosphate Ka of skeletal muscle glycogen synthase in calorie-restricted monkeys.

    Ortmeyer HK, Huang L, Larner J, Hansen BC.

    J Basic Clin Physiol Pharmacol. 1998;9(2-4):309-23.PMID: 10212841 [PubMed - indexed for MEDLINE]Related articles

    19.

    Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise.

    Thong FS, Derave W, Kiens B, Graham TE, Ursø B, Wojtaszewski JF, Hansen BF, Richter EA.

    Diabetes. 2002 Mar;51(3):583-90.PMID: 11872654 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes?

    Højlund K, Beck-Nielsen H.

    Curr Diabetes Rev. 2006 Nov;2(4):375-95. Review.PMID: 18220643 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data